Study of mutations in mtDNA (mitochondraial DNA) in urothelial (Bladder) cancer of bladder
Not Applicable
- Conditions
- Health Condition 1: C679- Malignant neoplasm of bladder, unspecified
- Registration Number
- CTRI/2020/02/023139
- Lead Sponsor
- KEM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
In summary: All Carcinoma bladder patients undergoing Transurethral resection / Radical cystectomy at Dept. of Urology, KEMH
Exclusion Criteria
All patient undergoing TURBT whose biopsy report turns out to be non malignant.
Patients who donâ??t give consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify the mutations in mt DNA gene in bladder cancer cases and comparing it with the normal tissue geneticsTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method To correlate the results of these mutations with clinical and pathological variables vis a vis grade, stage at presentationTimepoint: 1 year